Author

Michael Peter Vitek

Duke Medical CenterORCID 0000-0001-8140-8048Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 2 Research Focus:cell type annotation· 2 Approach:experimental assay· 2 Research Focus:benchmarking· 1 Research Focus:differential expression· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Organism:mouse· 1

Frequent Co-Authors

Adelaide L. WinkiD· 1 shared Ana L. González· 1 shared Daniel W. McVicariD· 1 shared David A. WinkiD· 1 shared Donna O. ButcheriD· 1 shared Elijah F. EdmondsoniD· 1 shared Elise L. FeminoiD· 1 shared Fatima ImtiaziD· 1 shared

Activity by Year

2023-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 36 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Adelaide L. WinkORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Pharmacology & ToxicologybioRxivPreprintJun 5, 2026

Anti-Polyamine Therapy Restrains Kidney Cyst Growth in an Orthologous Mouse Model of Autosomal Dominant Polycystic Kidney Disease

Katharina Hopp, Marie‐Louise T. Monaghan, Sizhao Lu…·Katherine I. Swenson-Fields

This study tests DFMO, an FDA-approved drug, in a mouse model of ADPKD and finds it reduces kidney cyst growth and improves kidney health.

DOI 10.64898/2026.06.02.729335

mousebulk RNA-seq

𝕏 PostBluesky

Cancer BiologybioRxivPreprintDec 21, 2023

Spatial analysis of NOS2 and COX2 interaction with T-effector cells reveals immunosuppressive landscapes associated with poor outcome in ER- breast cancer patients

Lisa A. Ridnour, Robert Y.S. Cheng, William F. Heinz…·David A. Wink

The paper identifies spatial interactions between NOS2, COX2, and T-effector cells in ER- breast cancer, linking these patterns to poor patient outcomes and suggesting potential therapeutic strategies.

2 citations

humanbulk RNA-seq

𝕏 PostBluesky